基因沉默和治疗中的基因传递:使用量子点的洞察力
Shrodha Mondal1, Jiko Raut1, Prithidipa Sahoo1
1Department of Chemistry, Visva-Bharati University, Santiniketan, WB 731235, India.
Frontiers in bioscience (Landmark edition)
|January 5, 2024
概括
量子点 (QD) 为基因疗法提供了一种新的解决方案,通过实时监测和精确传递小干扰RNA (siRNA) 或DNA等遗传材料. 这一进步提高了基因沉默和基因传递对各种疾病的效率和准确性.
科学领域:
- 生物技术和生物医学工程 生物技术和生物医学工程
- 分子生物学和遗传学分子生物学和遗传学
- 纳米技术和材料科学 材料科学
背景情况:
- 基因疗法和基因沉默显示出治疗许多疾病的前景,包括血友病,癌症和糖尿病.
- 目前的基因传递载体在精确准和实时监测治疗剂,如小干扰RNA (siRNA) 或DNA等方面面临挑战.
- 传统载体的非光性质阻碍了将遗传物质传递到目标组织的跟踪.
研究的目的:
- 探索量子点 (QD) 作为基因治疗和基因沉默的先进载体的潜力.
- 开发基于QD的纳米载体,以有效和可追踪地将遗传物质传递给特定的细胞.
- 为设计有效的基于QD的治疗应用交付系统提供框架.
主要方法:
- 量子点 (QD) 和遗传材料 (siRNA或DNA) 之间的复合体的形成.
- 利用QDs独特的光学和光特性,在交付和转染过程中实时监控和定位.
- 设计和测试基于QD的新型纳米载体,用于向基因传递.
主要成果:
- QD-siRNA和QD/DNA复合体在基因沉默和传递过程中成功进行了实时监测和精确定位.
- 量子点由于其双模态光学和光特性,表现出了多功能成像探测器的能力.
- 研究人员开发了独特的QD,可以有效地附着并将siRNA或DNA传递到目标位置.
结论:
- 量子点在开发用于基因治疗和基因沉默的高效纳米载体方面取得了重大进展.
- 基于QD的交付系统可以通过实现精确的定位和监控来克服传统载体的局限性.
- 这些基于QD的传递装置的应用有可能极大地提高基因沉默和基因传递领域,用于治疗各种疾病.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K


